Published in Exp Biol Med (Maywood) on April 01, 2001
Neural tube defects and folate: case far from closed. Nat Rev Neurosci (2006) 2.30
Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet (2004) 1.41
Effects of cultivation conditions on folate production by lactic acid bacteria. Appl Environ Microbiol (2003) 1.37
Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum Mol Genet (2008) 1.33
A genome-scale map of expression for a mouse brain section obtained using voxelation. Physiol Genomics (2007) 1.24
Alcohol, DNA methylation, and cancer. Alcohol Res (2013) 1.14
Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. PLoS One (2012) 1.01
Homocysteine toxicity in Escherichia coli is caused by a perturbation of branched-chain amino acid biosynthesis. J Bacteriol (2005) 0.99
Methionine transmethylation and transsulfuration in the piglet gastrointestinal tract. Proc Natl Acad Sci U S A (2007) 0.96
Neural tube defects, folic acid and methylation. Int J Environ Res Public Health (2013) 0.95
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro Oncol (2008) 0.95
Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol (2006) 0.91
Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol (2004) 0.88
Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study. Mol Genet Metab (2009) 0.85
Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility. Meta Gene (2015) 0.84
Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677C>T polymorphisms on folate and homocysteine concentrations. Eur J Hum Genet (2008) 0.83
The maternal folate hydrolase gene polymorphism is associated with neural tube defects in a high-risk Chinese population. Genes Nutr (2012) 0.83
Maternal folate, vitamin B12 and homocysteine levels in pregnancies affected by congenital malformations other than neural tube defects. Birth Defects Res A Clin Mol Teratol (2011) 0.82
Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era. J Nutr (2008) 0.80
Epigenetics and Cellular Metabolism. Genet Epigenet (2016) 0.80
How well do blood folate concentrations predict dietary folate intakes in a sample of Canadian lactating women exposed to high levels of folate? An observational study. BMC Pregnancy Childbirth (2007) 0.79
Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr (2007) 0.79
Severe but Not Moderate Vitamin B12 Deficiency Impairs Lipid Profile, Induces Adiposity, and Leads to Adverse Gestational Outcome in Female C57BL/6 Mice. Front Nutr (2016) 0.79
Functional role for the conformationally mobile phenylalanine 223 in the reaction of methylenetetrahydrofolate reductase from Escherichia coli. Biochemistry (2009) 0.78
Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis. J Neural Transm (Vienna) (2014) 0.77
PCMT1 gene polymorphisms, maternal folate metabolism, and neural tube defects: a case-control study in a population with relatively low folate intake. Genes Nutr (2013) 0.76
Association between MTHFR gene polymorphism and NTDs in Chinese Han population. Int J Clin Exp Med (2014) 0.75
Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions. Eur J Pharmacol (2012) 0.75
Association between chromosomal aberration of COX8C and tethered spinal cord syndrome: array-based comparative genomic hybridization analysis. Neural Regen Res (2016) 0.75
Analysis of MTHFR Gene C.677C>T and C.1298A>C Polymorphisms in Iranian Patients with Non-Syndromic Cleft Lip and Palate. Iran J Public Health (2014) 0.75
Approaches for the identification of genetic modifiers of nutrient dependent phenotypes: examples from folate. Front Nutr (2014) 0.75
Genetic association analyses of nitric oxide synthase genes and neural tube defects vary by phenotype. Birth Defects Res B Dev Reprod Toxicol (2013) 0.75
Gender and morphogenetic variability of patients with spina bifida occulta and spina bifida aperta: prospective population-genetic study. Hippokratia (2012) 0.75
Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans. Scientifica (Cairo) (2017) 0.75
Laxative treatment elevates plasma homocysteine: a study on a population-based Swedish sample of old people. Eur J Clin Pharmacol (2004) 0.75
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet (1995) 17.27
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet (1998) 4.96
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A (1991) 3.15
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med (1985) 2.49
Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet (1995) 2.35
Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet (1995) 2.00
Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism (1994) 1.81
Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM (1997) 1.59
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum (1998) 1.59
5,10-methylenetetrahydrofolate reductase (MTHFR) 677C-->T and 1298A-->C mutations are associated with DNA hypomethylation. J Med Genet (2004) 1.53
Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr (2000) 1.52
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48
Determinants of plasma homocysteine. Am J Clin Nutr (1998) 1.45
Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest (1996) 1.42
Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis (2006) 1.42
Molecular beacons: a new approach for semiautomated mutation analysis. Clin Chem (1998) 1.37
Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta (1996) 1.35
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.33
Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem (1995) 1.30
Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30
The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum (2001) 1.30
Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet (1992) 1.27
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med (Berl) (2001) 1.26
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology (2009) 1.25
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry (2006) 1.23
Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol (1993) 1.22
Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost (1998) 1.21
Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med (1991) 1.21
Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM (1997) 1.21
The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM (2007) 1.20
Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab (2001) 1.18
Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet (1985) 1.17
Decreased methylene tetrahydrofolate reductase activity due to the 677C-->T mutation in families with spina bifida offspring. J Mol Med (Berl) (1996) 1.17
Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril (1993) 1.17
Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril (2000) 1.16
Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol (2001) 1.15
Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr (1999) 1.14
Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb (1994) 1.14
Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest (1983) 1.13
Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM (2003) 1.12
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. J Clin Invest (1988) 1.11
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol (1998) 1.09
Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet (1997) 1.08
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford) (2002) 1.07
Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiol Aging (2003) 1.07
The molecular basis of Dutch infantile nephropathic cystinosis. Nephron (2001) 1.02
Reduced brain choline in homocystinuria due to remethylation defects. Neurology (2008) 1.02
Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology (1999) 1.01
Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation (1999) 1.00
SURFEIT-1 gene analysis and two-dimensional blue native gel electrophoresis in cytochrome c oxidase deficiency. Biochem Biophys Res Commun (1999) 0.99
Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab (2000) 0.98
Two novel missense mutations in the cystathionine beta-synthase gene in homocystinuric patients. Hum Genet (1995) 0.97
Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg (1994) 0.96
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis (1997) 0.95
Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr (2001) 0.95
Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol (2000) 0.95
Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol (1995) 0.95
A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels. Eur J Hum Genet (2001) 0.94
Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism (1983) 0.94
Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol (2000) 0.94
Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf) (2001) 0.93
Automated extraction and amplification of DNA from whole blood using a robotic workstation and an integrated thermocycler. Biotechnol Appl Biochem (2000) 0.92
5,10-Methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations are genetic determinants of elevated homocysteine. QJM (2003) 0.92
Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci (2001) 0.92
The homocysteine distribution: (mis)judging the burden. J Clin Epidemiol (2001) 0.91
Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest (1995) 0.91
Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology (1994) 0.91
Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol (1996) 0.90